Global Metabolic Biomarker Testing Market Size, Status and Forecast 2021-2027

代謝バイオマーカー検査の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Metabolic Biomarker Testing Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR3712
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:96
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥429,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥643,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥858,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、代謝バイオマーカー検査の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(分離技術、検出技術、その他)、用途別市場規模(創薬、ニュートリゲノミクス、毒物学検査、個別化医療、機能ゲノミクス、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・代謝バイオマーカー検査の市場動向
・企業の競争状況、市場シェア
・代謝バイオマーカー検査の種類別市場規模(分離技術、検出技術、その他)
・代謝バイオマーカー検査の用途別市場規模(創薬、ニュートリゲノミクス、毒物学検査、個別化医療、機能ゲノミクス、その他)
・代謝バイオマーカー検査の北米市場規模2016-2027(アメリカ、カナダ)
・代謝バイオマーカー検査の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・代謝バイオマーカー検査のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・代謝バイオマーカー検査の中南米市場規模2016-2027(メキシコ、ブラジル)
・代謝バイオマーカー検査の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Agilent Technologies、Bio-Rad Laboratories、Bruker、Danaher、Waters Corporation、Thermo Fisher Scientific、Biocrates Life Sciences、Human Metabolome Technologies)
・結論

In medicine, a biomarker is a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism.
Biomarkers are useful in a number of ways, including measuring the progress of disease, evaluating the most effective therapeutic regimes for a particular cancer type, and establishing long-term susceptibility to cancer or its recurrence. The parameter can be chemical, physical or biological. Biomarkers help in early diagnosis, disease prevention, drug target identification, drug response etc. Several biomarkers have been identified for many diseases such as serum LDL for cholesterol, blood pressure, and P53 gene[4]and MMPs [5] as tumor markers for cancer. Biomarkers are also seen as the key to personalised medicine, treatments individually tailored to specific patients for highly efficient intervention in disease processes. Often, such biomarkers indicate changes in metabolic processes.

Market Analysis and Insights: Global Metabolic Biomarker Testing Market
The global Metabolic Biomarker Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metabolic Biomarker Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metabolic Biomarker Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metabolic Biomarker Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metabolic Biomarker Testing market.

Global Metabolic Biomarker Testing Scope and Market Size
Metabolic Biomarker Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metabolic Biomarker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Technology and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Technology
Separation Techniques
Detection Techniques
Others

Segment by Application
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Agilent Technologies
Bio-Rad Laboratories
Bruker
Danaher
Waters Corporation
Thermo Fisher Scientific
Biocrates Life Sciences
Human Metabolome Technologies

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metabolic Biomarker Testing Market Size Growth Rate by Technology: 2016 VS 2021 VS 2027
1.2.2 Separation Techniques
1.2.3 Detection Techniques
1.2.4 Others
1.3 Market by Application
1.3.1 Global Metabolic Biomarker Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Drug Discovery
1.3.3 Nutrigenomics
1.3.4 Toxicology Testing
1.3.5 Personalized Medicine
1.3.6 Functional Genomics
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Metabolic Biomarker Testing Market Perspective (2016-2027)
2.2 Metabolic Biomarker Testing Growth Trends by Regions
2.2.1 Metabolic Biomarker Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metabolic Biomarker Testing Historic Market Share by Regions (2016-2021)
2.2.3 Metabolic Biomarker Testing Forecasted Market Size by Regions (2022-2027)
2.3 Metabolic Biomarker Testing Industry Dynamic
2.3.1 Metabolic Biomarker Testing Market Trends
2.3.2 Metabolic Biomarker Testing Market Drivers
2.3.3 Metabolic Biomarker Testing Market Challenges
2.3.4 Metabolic Biomarker Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Metabolic Biomarker Testing Players by Revenue
3.1.1 Global Top Metabolic Biomarker Testing Players by Revenue (2016-2021)
3.1.2 Global Metabolic Biomarker Testing Revenue Market Share by Players (2016-2021)
3.2 Global Metabolic Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metabolic Biomarker Testing Revenue
3.4 Global Metabolic Biomarker Testing Market Concentration Ratio
3.4.1 Global Metabolic Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabolic Biomarker Testing Revenue in 2020
3.5 Metabolic Biomarker Testing Key Players Head office and Area Served
3.6 Key Players Metabolic Biomarker Testing Product Solution and Service
3.7 Date of Enter into Metabolic Biomarker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Metabolic Biomarker Testing Breakdown Data by Technology
4.1 Global Metabolic Biomarker Testing Historic Market Size by Technology (2016-2021)
4.2 Global Metabolic Biomarker Testing Forecasted Market Size by Technology (2022-2027)

5 Metabolic Biomarker Testing Breakdown Data by Application
5.1 Global Metabolic Biomarker Testing Historic Market Size by Application (2016-2021)
5.2 Global Metabolic Biomarker Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Metabolic Biomarker Testing Market Size (2016-2027)
6.2 North America Metabolic Biomarker Testing Market Size by Technology
6.2.1 North America Metabolic Biomarker Testing Market Size by Technology (2016-2021)
6.2.2 North America Metabolic Biomarker Testing Market Size by Technology (2022-2027)
6.2.3 North America Metabolic Biomarker Testing Market Size by Technology (2016-2027)
6.3 North America Metabolic Biomarker Testing Market Size by Application
6.3.1 North America Metabolic Biomarker Testing Market Size by Application (2016-2021)
6.3.2 North America Metabolic Biomarker Testing Market Size by Application (2022-2027)
6.3.3 North America Metabolic Biomarker Testing Market Size by Application (2016-2027)
6.4 North America Metabolic Biomarker Testing Market Size by Country
6.4.1 North America Metabolic Biomarker Testing Market Size by Country (2016-2021)
6.4.2 North America Metabolic Biomarker Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Metabolic Biomarker Testing Market Size (2016-2027)
7.2 Europe Metabolic Biomarker Testing Market Size by Technology
7.2.1 Europe Metabolic Biomarker Testing Market Size by Technology (2016-2021)
7.2.2 Europe Metabolic Biomarker Testing Market Size by Technology (2022-2027)
7.2.3 Europe Metabolic Biomarker Testing Market Size by Technology (2016-2027)
7.3 Europe Metabolic Biomarker Testing Market Size by Application
7.3.1 Europe Metabolic Biomarker Testing Market Size by Application (2016-2021)
7.3.2 Europe Metabolic Biomarker Testing Market Size by Application (2022-2027)
7.3.3 Europe Metabolic Biomarker Testing Market Size by Application (2016-2027)
7.4 Europe Metabolic Biomarker Testing Market Size by Country
7.4.1 Europe Metabolic Biomarker Testing Market Size by Country (2016-2021)
7.4.2 Europe Metabolic Biomarker Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Metabolic Biomarker Testing Market Size (2016-2027)
8.2 Asia-Pacific Metabolic Biomarker Testing Market Size by Technology
8.2.1 Asia-Pacific Metabolic Biomarker Testing Market Size by Technology (2016-2021)
8.2.2 Asia-Pacific Metabolic Biomarker Testing Market Size by Technology (2022-2027)
8.2.3 Asia-Pacific Metabolic Biomarker Testing Market Size by Technology (2016-2027)
8.3 Asia-Pacific Metabolic Biomarker Testing Market Size by Application
8.3.1 Asia-Pacific Metabolic Biomarker Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metabolic Biomarker Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metabolic Biomarker Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Metabolic Biomarker Testing Market Size by Region
8.4.1 Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Metabolic Biomarker Testing Market Size (2016-2027)
9.2 Latin America Metabolic Biomarker Testing Market Size by Technology
9.2.1 Latin America Metabolic Biomarker Testing Market Size by Technology (2016-2021)
9.2.2 Latin America Metabolic Biomarker Testing Market Size by Technology (2022-2027)
9.2.3 Latin America Metabolic Biomarker Testing Market Size by Technology (2016-2027)
9.3 Latin America Metabolic Biomarker Testing Market Size by Application
9.3.1 Latin America Metabolic Biomarker Testing Market Size by Application (2016-2021)
9.3.2 Latin America Metabolic Biomarker Testing Market Size by Application (2022-2027)
9.3.3 Latin America Metabolic Biomarker Testing Market Size by Application (2016-2027)
9.4 Latin America Metabolic Biomarker Testing Market Size by Country
9.4.1 Latin America Metabolic Biomarker Testing Market Size by Country (2016-2021)
9.4.2 Latin America Metabolic Biomarker Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Metabolic Biomarker Testing Market Size (2016-2027)
10.2 Middle East & Africa Metabolic Biomarker Testing Market Size by Technology
10.2.1 Middle East & Africa Metabolic Biomarker Testing Market Size by Technology (2016-2021)
10.2.2 Middle East & Africa Metabolic Biomarker Testing Market Size by Technology (2022-2027)
10.2.3 Middle East & Africa Metabolic Biomarker Testing Market Size by Technology (2016-2027)
10.3 Middle East & Africa Metabolic Biomarker Testing Market Size by Application
10.3.1 Middle East & Africa Metabolic Biomarker Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metabolic Biomarker Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metabolic Biomarker Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Metabolic Biomarker Testing Market Size by Country
10.4.1 Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Metabolic Biomarker Testing Introduction
11.1.4 Agilent Technologies Revenue in Metabolic Biomarker Testing Business (2016-2021)
11.1.5 Agilent Technologies Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Metabolic Biomarker Testing Introduction
11.2.4 Bio-Rad Laboratories Revenue in Metabolic Biomarker Testing Business (2016-2021)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Bruker
11.3.1 Bruker Company Details
11.3.2 Bruker Business Overview
11.3.3 Bruker Metabolic Biomarker Testing Introduction
11.3.4 Bruker Revenue in Metabolic Biomarker Testing Business (2016-2021)
11.3.5 Bruker Recent Development
11.4 Danaher
11.4.1 Danaher Company Details
11.4.2 Danaher Business Overview
11.4.3 Danaher Metabolic Biomarker Testing Introduction
11.4.4 Danaher Revenue in Metabolic Biomarker Testing Business (2016-2021)
11.4.5 Danaher Recent Development
11.5 Waters Corporation
11.5.1 Waters Corporation Company Details
11.5.2 Waters Corporation Business Overview
11.5.3 Waters Corporation Metabolic Biomarker Testing Introduction
11.5.4 Waters Corporation Revenue in Metabolic Biomarker Testing Business (2016-2021)
11.5.5 Waters Corporation Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Metabolic Biomarker Testing Introduction
11.6.4 Thermo Fisher Scientific Revenue in Metabolic Biomarker Testing Business (2016-2021)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Biocrates Life Sciences
11.7.1 Biocrates Life Sciences Company Details
11.7.2 Biocrates Life Sciences Business Overview
11.7.3 Biocrates Life Sciences Metabolic Biomarker Testing Introduction
11.7.4 Biocrates Life Sciences Revenue in Metabolic Biomarker Testing Business (2016-2021)
11.7.5 Biocrates Life Sciences Recent Development
11.8 Human Metabolome Technologies
11.8.1 Human Metabolome Technologies Company Details
11.8.2 Human Metabolome Technologies Business Overview
11.8.3 Human Metabolome Technologies Metabolic Biomarker Testing Introduction
11.8.4 Human Metabolome Technologies Revenue in Metabolic Biomarker Testing Business (2016-2021)
11.8.5 Human Metabolome Technologies Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Metabolic Biomarker Testing Market Size Growth Rate by Technology (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Separation Techniques
Table 3. Key Players of Detection Techniques
Table 4. Key Players of Others
Table 5. Global Metabolic Biomarker Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Metabolic Biomarker Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Metabolic Biomarker Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Metabolic Biomarker Testing Market Share by Regions (2016-2021)
Table 9. Global Metabolic Biomarker Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Metabolic Biomarker Testing Market Share by Regions (2022-2027)
Table 11. Metabolic Biomarker Testing Market Trends
Table 12. Metabolic Biomarker Testing Market Drivers
Table 13. Metabolic Biomarker Testing Market Challenges
Table 14. Metabolic Biomarker Testing Market Restraints
Table 15. Global Metabolic Biomarker Testing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Metabolic Biomarker Testing Market Share by Players (2016-2021)
Table 17. Global Top Metabolic Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolic Biomarker Testing as of 2020)
Table 18. Ranking of Global Top Metabolic Biomarker Testing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Metabolic Biomarker Testing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Metabolic Biomarker Testing Product Solution and Service
Table 22. Date of Enter into Metabolic Biomarker Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Metabolic Biomarker Testing Market Size by Technology (2016-2021) (US$ Million)
Table 25. Global Metabolic Biomarker Testing Revenue Market Share by Technology (2016-2021)
Table 26. Global Metabolic Biomarker Testing Forecasted Market Size by Technology (2022-2027) (US$ Million)
Table 27. Global Metabolic Biomarker Testing Revenue Market Share by Technology (2022-2027) & (US$ Million)
Table 28. Global Metabolic Biomarker Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Metabolic Biomarker Testing Revenue Market Share by Application (2016-2021)
Table 30. Global Metabolic Biomarker Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Metabolic Biomarker Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Metabolic Biomarker Testing Market Size by Technology (2016-2021) (US$ Million)
Table 33. North America Metabolic Biomarker Testing Market Size by Technology (2022-2027) & (US$ Million)
Table 34. North America Metabolic Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Metabolic Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Metabolic Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Metabolic Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Metabolic Biomarker Testing Market Size by Technology (2016-2021) (US$ Million)
Table 39. Europe Metabolic Biomarker Testing Market Size by Technology (2022-2027) & (US$ Million)
Table 40. Europe Metabolic Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Metabolic Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Metabolic Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Metabolic Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Metabolic Biomarker Testing Market Size by Technology (2016-2021) (US$ Million)
Table 45. Asia-Pacific Metabolic Biomarker Testing Market Size by Technology (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Metabolic Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Metabolic Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Metabolic Biomarker Testing Market Size by Technology (2016-2021) (US$ Million)
Table 51. Latin America Metabolic Biomarker Testing Market Size by Technology (2022-2027) & (US$ Million)
Table 52. Latin America Metabolic Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Metabolic Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Metabolic Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Metabolic Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Metabolic Biomarker Testing Market Size by Technology (2016-2021) (US$ Million)
Table 57. Middle East & Africa Metabolic Biomarker Testing Market Size by Technology (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Metabolic Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Metabolic Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 62. Agilent Technologies Company Details
Table 63. Agilent Technologies Business Overview
Table 64. Agilent Technologies Metabolic Biomarker Testing Product
Table 65. Agilent Technologies Revenue in Metabolic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 66. Agilent Technologies Recent Development
Table 67. Bio-Rad Laboratories Company Details
Table 68. Bio-Rad Laboratories Business Overview
Table 69. Bio-Rad Laboratories Metabolic Biomarker Testing Product
Table 70. Bio-Rad Laboratories Revenue in Metabolic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 71. Bio-Rad Laboratories Recent Development
Table 72. Bruker Company Details
Table 73. Bruker Business Overview
Table 74. Bruker Metabolic Biomarker Testing Product
Table 75. Bruker Revenue in Metabolic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 76. Bruker Recent Development
Table 77. Danaher Company Details
Table 78. Danaher Business Overview
Table 79. Danaher Metabolic Biomarker Testing Product
Table 80. Danaher Revenue in Metabolic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 81. Danaher Recent Development
Table 82. Waters Corporation Company Details
Table 83. Waters Corporation Business Overview
Table 84. Waters Corporation Metabolic Biomarker Testing Product
Table 85. Waters Corporation Revenue in Metabolic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 86. Waters Corporation Recent Development
Table 87. Thermo Fisher Scientific Company Details
Table 88. Thermo Fisher Scientific Business Overview
Table 89. Thermo Fisher Scientific Metabolic Biomarker Testing Product
Table 90. Thermo Fisher Scientific Revenue in Metabolic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 91. Thermo Fisher Scientific Recent Development
Table 92. Biocrates Life Sciences Company Details
Table 93. Biocrates Life Sciences Business Overview
Table 94. Biocrates Life Sciences Metabolic Biomarker Testing Product
Table 95. Biocrates Life Sciences Revenue in Metabolic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 96. Biocrates Life Sciences Recent Development
Table 97. Human Metabolome Technologies Company Details
Table 98. Human Metabolome Technologies Business Overview
Table 99. Human Metabolome Technologies Revenue in Metabolic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 100. Human Metabolome Technologies Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metabolic Biomarker Testing Market Share by Technology: 2020 VS 2027
Figure 2. Separation Techniques Features
Figure 3. Detection Techniques Features
Figure 4. Others Features
Figure 5. Global Metabolic Biomarker Testing Market Share by Application: 2020 VS 2027
Figure 6. Drug Discovery Case Studies
Figure 7. Nutrigenomics Case Studies
Figure 8. Toxicology Testing Case Studies
Figure 9. Personalized Medicine Case Studies
Figure 10. Functional Genomics Case Studies
Figure 11. Others Case Studies
Figure 12. Metabolic Biomarker Testing Report Years Considered
Figure 13. Global Metabolic Biomarker Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Metabolic Biomarker Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Metabolic Biomarker Testing Market Share by Regions: 2020 VS 2027
Figure 16. Global Metabolic Biomarker Testing Market Share by Regions (2022-2027)
Figure 17. Global Metabolic Biomarker Testing Market Share by Players in 2020
Figure 18. Global Top Metabolic Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolic Biomarker Testing as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Metabolic Biomarker Testing Revenue in 2020
Figure 20. Global Metabolic Biomarker Testing Revenue Market Share by Technology (2016-2021)
Figure 21. Global Metabolic Biomarker Testing Revenue Market Share by Technology (2022-2027)
Figure 22. North America Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Metabolic Biomarker Testing Market Share by Technology (2016-2027)
Figure 24. North America Metabolic Biomarker Testing Market Share by Application (2016-2027)
Figure 25. North America Metabolic Biomarker Testing Market Share by Country (2016-2027)
Figure 26. United States Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Metabolic Biomarker Testing Market Share by Technology (2016-2027)
Figure 30. Europe Metabolic Biomarker Testing Market Share by Application (2016-2027)
Figure 31. Europe Metabolic Biomarker Testing Market Share by Country (2016-2027)
Figure 32. Germany Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Metabolic Biomarker Testing Market Share by Technology (2016-2027)
Figure 40. Asia-Pacific Metabolic Biomarker Testing Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Metabolic Biomarker Testing Market Share by Region (2016-2027)
Figure 42. China Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Metabolic Biomarker Testing Market Share by Technology (2016-2027)
Figure 50. Latin America Metabolic Biomarker Testing Market Share by Application (2016-2027)
Figure 51. Latin America Metabolic Biomarker Testing Market Share by Country (2016-2027)
Figure 52. Mexico Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Metabolic Biomarker Testing Market Share by Technology (2016-2027)
Figure 56. Middle East & Africa Metabolic Biomarker Testing Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Metabolic Biomarker Testing Market Share by Country (2016-2027)
Figure 58. Turkey Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Metabolic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Agilent Technologies Revenue Growth Rate in Metabolic Biomarker Testing Business (2016-2021)
Figure 62. Bio-Rad Laboratories Revenue Growth Rate in Metabolic Biomarker Testing Business (2016-2021)
Figure 63. Bruker Revenue Growth Rate in Metabolic Biomarker Testing Business (2016-2021)
Figure 64. Danaher Revenue Growth Rate in Metabolic Biomarker Testing Business (2016-2021)
Figure 65. Waters Corporation Revenue Growth Rate in Metabolic Biomarker Testing Business (2016-2021)
Figure 66. Thermo Fisher Scientific Revenue Growth Rate in Metabolic Biomarker Testing Business (2016-2021)
Figure 67. Biocrates Life Sciences Revenue Growth Rate in Metabolic Biomarker Testing Business (2016-2021)
Figure 68. Human Metabolome Technologies Revenue Growth Rate in Metabolic Biomarker Testing Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[代謝バイオマーカー検査の世界市場規模・現状・予測2021年-2027年] (Global Metabolic Biomarker Testing Market Size, Status and Forecast 2021-2027 / QY21APR3712)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆